Embla Medical Secures Seven-Year NIB Financing for Healthcare Technology Development

Image: Embla Medical

(IN BRIEF) NIB has signed a EUR 50 million, seven-year loan with Embla Medical hf. The financing will support Embla Medical’s research and development activities from 2027 to 2029, focusing on prosthetics, orthotics and related healthcare solutions. The project includes work on new and improved products, materials, digital technologies and patient care. Embla Medical is headquartered in Iceland and provides prosthetics, orthotics and mobility solutions in more than 120 markets worldwide.

(PRESS RELEASE) HELSINKI, 4-Aug-2026 — /EuropaWire/ — NIB has signed a EUR 50 million loan agreement with Embla Medical hf. to support the company’s research and development activities.

The financing has a maturity of seven years and will be used to fund Embla Medical’s R&D programme during the 2027–2029 period.

The investment will support innovation in the healthcare sector and the development of advanced medical technologies.

Embla Medical will use the financing for the development of new and improved prosthetics, orthotics and related healthcare solutions.

The work will include advances in materials, digital technologies and patient care.

Jeanette Vitasp, NIB Vice-President and Head of Lending, said innovation in medical technology plays an important role in improving quality of life and supporting sustainable healthcare systems.

Embla Medical hf. is a global provider of prosthetics, orthotics and mobility solutions.

The company is headquartered in Iceland and operates in more than 120 markets worldwide.

Through the financing, NIB is supporting the continued development of medical technologies designed to improve mobility, patient outcomes and access to advanced healthcare solutions.

NIB is the international financial institution of Denmark, Estonia, Finland, Iceland, Latvia, Lithuania, Norway, and Sweden. The Bank finances projects that improve productivity and benefit the environment of the Nordic-Baltic region. The Bank is headquartered in Helsinki with a regional hub in Riga. NIB has the highest possible credit rating, AAA/Aaa, with S&P Global Ratings and Moody’s.

Contacts
Stefán Jón Fridriksson, Senior Banker, Country Lead Iceland, +358 10 618 0512, stefan.fridriksson@nib.int

Oliver Mølvang Hermansen, Associate Communications Officer, at +358 10 618 0225, oliver.hermansen@nib.int

SOURCE: Nordic Investment Bank